FindTrial
Sign In

Chinese moyamoya disease cohort study (C-MMD)

Chinese moyamoya disease cohort study (C-MMD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064160
Enrollment
Unknown
Registered
2022-09-28
Start date
2022-09-28
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya Disease

Interventions

Moyamoya Disease:N/A

Sponsors

Department of Neurosurgery, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with moyamoya disease diagnosed by DSA, MRI, or MRA; 2. Patients who can complete the relevant examinations involved in this study.

Exclusion criteria

Exclusion criteria: 1. Incomplete medical records; 2. Patients or guardians who were unwilling to join the study.

Design outcomes

Primary

MeasureTime frame
Suzuki Stage;collateral circulation grading score;stroke;mRS score;—

Secondary

MeasureTime frame
BMI;SBP;DBP;homocysteine;triglyceride;total cholesterol;high-density lipoprotein (HDL) cholesterol;low-density lipoprotein (LDL) cholesterol;Glucose;—

Countries

China

Contacts

Public ContactLian Duan

Department of Neurosurgery, Chinese PLA General Hospital

duanlian307@sina.com+86 13911365592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026